Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,930 shares at $525.00 ($1.0M) on 2021-06-07, disclosed to the SEC on 2021-06-08.
Open-market sale of $1.0M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2020-10-06 | $5.5M | — | Filing → |